| 0.290 0 (0%) 10-26 17:35 |
|
| Open: | 0.190 |
| High: | 0.296 |
| Low: | 0.190 |
| Pre. close: | 0.290 |
| Volume: | 1,390,891 |
| Avg. volume: | 201,577 |
| MA (50): | 0.193 |
| MA (200): | 0.300 |
| Year high: | 1.218 |
| Year low: | 0.112 |
| Market cap: | 0(M) |
| EPS: | -0.767 |
| PE ratio: | -0.378 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Wed, 31 Jul 2024
The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence - Frontiers
Fri, 08 Mar 2024
Engineered MgO nanoparticles for cartilage-bone synergistic therapy - Science | AAAS
Thu, 28 Sep 2023
Biomimetic Therapeutics for Bone Regeneration: A Perspective on Antiaging Strategies - Wiley Online Library
Mon, 14 Aug 2023
Editorial: Diagnosis and treatment of bone metastases - Frontiers
Mon, 19 Jun 2023
BioSenic halts ALLOB development - European Biotechnology Magazine
Wed, 26 Oct 2022
Bone Therapeutics joins biotech name change rage, rebranding as BioSenic - Fierce Pharma
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.